Print this page    •   Back to Web version of article

From Research to Reality: Investing in HIV Prevention in a Challenging Landscape

September 2013

The HIV Vaccines & Microbicides Resource Tracking Working Group, comprised of AVAC, the International AIDS Vaccine Initiative (IAVI), and the Joint United Nations Programme on HIV/AIDS (UNAIDS), uses a comprehensive methodology to track annual research and development (R&D) investment trends in biomedical HIV prevention. Information collected in previous years has been used by the Working Group and others to monitor levels of effort, analyze the significance of investment trends and assess the impact of public policies aimed at accelerating scientific progress towards new prevention tools against HIV.


HIV Prevention R&D Global Investment by Region in 2012
HIV Prevention R&D Trial Participants by Region in 2012


Data compiled by the HIV Vaccines & Microbicides Resource Tracking Working Group.




This article was provided by AVAC: Global Advocacy for HIV Prevention. It is a part of the publication Px Wire. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/72620/from-research-to-reality-investing-in-hiv-preventi.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.